53 completed, 6 unknown, 5 terminated, 1 withdrawn. 17 Phase 1, 17 Phase 2, 5 Not applicable, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 17 | Completed 15, Terminated 1, Unknown 1 |
| Phase 2 | 17 | Completed 14, Terminated 2, Unknown 1 |
| Not applicable | 5 | Completed 4, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow this drug Literature Review of Immunologic Techniques trials Research Report on Immunologic Techniques
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia gene expression analysis, protein expression analysis, fluorescence activated cell sorting - Leukemia | Completed | Children's Oncology Group | 75 | 2012-09-01 | 2016-05-18 | |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma cyclophosphamide, aldesleukin, autologous tumor cell vaccine - Recurrent Melanoma, Stage IV Melanoma | Phase 1 | Completed | Fred Hutchinson Cancer Center | 12 | 2012-03-01 | 2014-04-21 |
| Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial fluorescence in situ hybridization, immunohistochemistry staining method, immunologic technique - Breast Cancer | Unknown | NSABP Foundation Inc | 1874 | 2011-11-01 | 2015-05-08 | |
| Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim flow cytometry, immunologic technique, laboratory biomarker analysis - Melanoma (Skin) | Completed | Eastern Cooperative Oncology Group | 48 | 2011-06-28 | 2017-05-17 | |
| Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer polymorphism analysis, immunologic technique, laboratory biomarker analysis - Pancreatic Cancer | Completed | Alliance for Clinical Trials in Oncology | 265 | 2011-06-01 | 2016-06-29 | |
| Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer pazopanib hydrochloride, laboratory biomarker analysis, immunologic technique - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 2 | Completed | City of Hope Medical Center | 28 | 2010-12-08 | 2022-06-08 |
| Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors epirubicin hydrochloride, panobinostat, gene expression analysis - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | University of California, San Francisco | 40 | 2009-09-13 | 2017-03-24 |
| Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia mutation analysis, polymerase chain reaction, immunologic technique - Leukemia | Completed | ECOG-ACRIN Cancer Research Group | 30 | 2009-05-15 | 2017-05-17 | |
| White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy white button mushroom extract, flow cytometry, immunologic technique - Prostate Cancer | Phase 1 | Completed | City of Hope Medical Center | 36 | 2009-01-29 | 2022-03-31 |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia clofarabine, daunorubicin hydrochloride, cytogenetic analysis - Leukemia | Phase 2 | Terminated | Roswell Park Cancer Institute | 21 | 2008-12-01 | 2016-08-17 |
| Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment hydroxychloroquine, temsirolimus, electron microscopy - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 40 | 2008-10-01 | 2019-04-16 |
| Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer exercise intervention, counseling intervention, gas chromatography - Breast Cancer, Healthy, no Evidence of Disease | Not applicable | Completed | Abramson Cancer Center at Penn Medicine | 183 | 2008-10-01 | 2020-04-16 |
| Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer CpG oligodeoxynucleotide, HER-2/neu peptide vaccine, MUC-1 peptide vaccine - Breast Cancer | Early Phase 1 | Completed | Mayo Clinic | 45 | 2008-08-28 | 2018-10-31 |
| S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia polyacrylamide gel electrophoresis, western blotting, immunologic technique - Leukemia | Completed | SWOG Cancer Research Network | 132 | 2008-08-01 | 2015-03-06 | |
| Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma bortezomib, dexamethasone, pegylated liposomal doxorubicin hydrochloride - Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Unknown | Oncotherapeutics | 35 | 2008-07-01 | 2013-12-18 |
| Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma B7-DC cross-linking antibody rHIgM12B7, flow cytometry, immunologic technique - Melanoma (Skin) | Phase 1 | Completed | Mayo Clinic | 7 | 2008-04-08 | 2017-05-25 |
| Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer biologic sample preservation procedure, immunologic technique, laboratory biomarker analysis - Leukemia, Multiple Myeloma and Plasma Cell Neoplasm | Terminated | Case Comprehensive Cancer Center | 34 | 2008-04-01 | 2015-10-09 | |
| SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors HDAC inhibitor SB939, immunoenzyme technique, immunohistochemistry staining method - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | NCIC Clinical Trials Group | 39 | 2007-09-14 | 2023-08-04 |
| Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma epirubicin hydrochloride, sulindac, immunologic technique - Melanoma (Skin) | Phase 2 | Completed | Cancer Trials Ireland | 32 | 2007-08-01 | 2014-12-31 |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer flow cytometry, fluorescence activated cell sorting, immunohistochemistry staining method - Breast Cancer | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 43 | 2007-08-01 | 2015-10-12 |
Showing 20 of 65. Sign in to see all of them.
Breast Neoplasms (14) · Leukemia (13) · Congenital Abnormalities (11) · Leukemia, Myeloid, Acute (11) · Melanoma (10) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (9) · Multiple Myeloma (8) · Lymphoma, Follicular (6) · Myelodysplastic Syndromes (6) · Neoplasms, Plasma Cell (6) · Burkitt Lymphoma (5) · Leukemia, Lymphocytic, Chronic, B-Cell (5) · Leukemia, Myeloid, Accelerated Phase (5) · Lymphoma (5) · Lymphoma, B-Cell, Marginal Zone (5)
Case Comprehensive Cancer Center (5) · ECOG-ACRIN Cancer Research Group (5) · Fred Hutchinson Cancer Center (5) · Mayo Clinic (4) · Memorial Sloan Kettering Cancer Center (4) · Vanderbilt-Ingram Cancer Center (4) · City of Hope Medical Center (3) · University of Washington (3) · Abramson Cancer Center at Penn Medicine (2) · Alliance for Clinical Trials in Oncology (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · Vanderbilt University Medical Center (2) · Cancer Trials Ireland (1) · Children's Oncology Group (1) · Cytheris SA (1)
United States (46) · Ireland (2) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Jeffrey A. Sosman, MD (2) · Kenneth G. Lucas, MD (2) · Wendell G. Yarbrough, MD, FACS (2) · Adolfo A. Ferrando, MD, PhD (1) · Alan K. Burnett, MD, FRCP (1) · Alan Venook, MD (1) · Angela Davies, MD (1) · Angela Dispenzieri, MD (1) · Ann Woolfrey, MD (1) · Ari M. Melnick, MD (1) · Balazs Halmos, MD (1) · Barbara A Pockai, M.D. (1) · Barbara Goff (1) · Barbara Murphy, MD (1) · Brian Rini (1)
PMID 21285985, PMID 21677464, PMID 21719601, PMID 21873334, PMID 24383844, PMID 24786393, PMID 25425683, PMID 25527568, PMID 25989179, PMID 26903311, PMID 28679643, PMID 34615429, PMID 34875023, PMID 36326756
P30CA015083 (4), P30CA043703 (4), P30CA068485 (3), P30CA006973 (2), P30CA033572 (2), K12CA076930 (1), P01CA018029 (1), P30CA008748 (1), P30CA012197 (1), P30CA014520 (1), P30CA015704 (1), P30CA093373 (1), R01AI053193 (1), R01AI058148 (1), R01CA129382 (1)